Today on DrugResearcher.com   AZ hoping its prostate cancer drug will succeed where Abbott's failed GlaxoSmithKline cancer vaccine 'impressive' EU to fund stem cell assay development collaboration AstraZeneca teams up to fight Japan's drug lag Drugs moving into the clinic: 29

Related Industry News   Pfizer looks to new delivery systems to boost Exubera SAFC in latest biomanufacturing capacity expansion Nobilon nabs adjuvant for new flu jabs Clinical trials in India: 'The wind is blowing'

Breaking News on Drug Discovery
Daily  Thursday 27 September 2007		Forward to a colleague

	Company Profile CHIRALPAK® IC CHIRAL TECHNOLOGIES EUROPE announce the launch of CHIRALPAK® IC. The combination of CHIRALPAK® IA , IB and now IC provides a screening set of columns with exceptionally high success rates. The chiral separation of > 99% of all small molecules is attained using just 3 columns and four mobile phase combinations... Click Here Access Full Stories AZ hoping its prostate cancer drug will succeed where Abbott's failed After decades of limited options and false hopes, prostate cancer sufferers will be hoping AstraZeneca's (AZ) new drug can succeed where Abbott's failed... Read GlaxoSmithKline cancer vaccine 'impressive' GlaxoSmithKline (GSK) has taken a step closer to a true targeted cancer therapy, and its vaccine, which 'educates' the immune system to kill tumour cells, has showed 'impressive' results in its latest clinical... Read EU to fund stem cell assay development collaboration Stem Cell Sciences (SCS) has received a €2.4m boost from the European Union (EU) for its new drug screening development programme using neutral stem cells... Read AstraZeneca teams up to fight Japan's drug lag AstraZeneca has teamed up with a Japanese university to co-conduct clinical trials in an effort to tackle Japan's so-called 'drug lag'... Read Drugs moving into the clinic: 29 The latest in a series of periodic roundups of drugs that have moved from preclinical research into clinical testing via the announcement of a Phase I trial or an application for a trial to industry regulators... Read
	All News Headlines for: September | August | July
	Technical / White Paper DeltaDOT label free analysis of biomolecules Faster, higher quality results at a fraction of the cost of conventional approaches. Analyse & Quantify Antibodies, Proteins and Small molecules - with high resolution, sensitivity & reproducibility... Click Here
	Related Industry News Pfizer looks to new delivery systems to boost Exubera Pfizer has started development on two next generation inhalers with the aim of replacing the underperforming Exubera inhaled insulin device... Read SAFC in latest biomanufacturing capacity expansion Contract manufacturer SAFC is investing $29m (€21m) to expand its Jerusalem, Israel manufacturing capacity for high-potency biologics... Read Nobilon nabs adjuvant for new flu jabs Organon subsidiary Nobilon has got its hands on a promising new adjuvant that it plans to use to enhance it pandemic and seasonal flu vaccines... Read Clinical trials in India: 'The wind is blowing' An industry veteran gives Outsourcing-Pharma.com an update on the state of the contract research organisation (CRO) industry in India... Read Inside India: special series Indian manufacturers need to lose generic mindset Indian drug manufacturers need to rid themselves of their generic mindset in order to evolve and remain competitive for the future. Read Sponsored Link DOSE IT - For easy dispensing of media and buffers Finally a programmable peristaltic pump with easy on-screen instructions and self-explanatory operation! If you are tired of complex pump operation, watch the DOSE IT online video or download the product information on the INTEGRA Biosciences website... Click Here Previous Headlines Merck failure not our fault, says Crucell Dutch firm Crucell is hastily trying to reassure investors that its popular cell line technology, PER.C6, was not to blame for the failure of Merck's hotly touted HIV vaccine last week... Read IOTA breaks into fragment-based screening field A new player, IOTA Pharmaceuticals, has entered the fragment-based drug discovery (FBDD) services arena this week. ... Read Plexera and MitoSciences to develop ADME/Tox arrays Plexera and MitoSciences will collaborate to commercialise an antibody array designed to study mitochondrial function that could become an integral part of ADME/Tox (absorption, distribution, metabolism, excretion... Read New schizophrenia target found in the glutamate system US researchers have published new results that indicate the metabotropic glutamate 5 receptor (mGluR5) could be a potential target for new schizophrenia therapies... Read BMS buys biologics partner, strengthens oncology Bristol-Myers Squibb (BMS) will pay up to $490m (€348m) for Adnexus Therapeutics, as it continues its transformation into a biopharmaceutical company and strengthens its oncology pipeline... Read Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analysis and instrumentation Assays and screening Cell culture & Equipment Chromatography Compounds and consumables Contract services (outsourcing) Drug discovery Genomics / Proteomics Informatics & IT Lab equipment & consumables Liquid handling and automation Liquid handling and sample preparation Production technologies Separation and purification

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@DrugResearcher.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com